Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 4 , Pages 296-303 , July 2010

Plasma circulatory markers in male and female patients with coronary artery disease

  • Hem C. Jha, MSc

      Affiliations

    • Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India
  • ,
  • Aabha Divya, MBBS

      Affiliations

    • All India Institute of Medical Sciences, New Delhi, India
  • ,
  • Jagdish Prasad, MS, DNB, Mch

      Affiliations

    • Department of Cardiothoracic and Vascular Surgery, Safdarjung Hospital, New Delhi, India
  • ,
  • Aruna Mittal, PhD

      Affiliations

    • Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, India
    • Corresponding Author InformationCorresponding author: Aruna Mittal, PhD, Institute of Pathology (Indian Council of Medical Research), Safdarjung Hospital Campus, Post Box, no-4909, New Delhi 110029, India.

References 

  1. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290:932–940
  2. Ross R. Atherosclerosis- an inflammatory disease. N Engl J Med. 1999;340:115–126
  3. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874
  4. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med. 2002;252:283–294
  5. Hebenstreit D, Wirnsberger G, Horejs-Hoeck J, et al. Signaling mechanisms, interaction partners, and target genes of STAT6. Cytokine Growth Factor Rev. 2006;17:173–188
  6. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology. 2007;58:513–522
  7. Wuthrich RP, Jevnikar AM, Takei F, et al. Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated in autoimmune murine lupus nephritis. Am J Pathol. 1990;136:441–450
  8. Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses. 2004;62:499–506
  9. Walpola PL, Gotlieb AI, Cybulsky MI, et al. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol. 1995;5:2–10
  10. Kosuge M, Ebina T, Hibi K, et al. Value of serial C-reactive protein measurements in non ST-segment elevation acute coronary syndromes. Clin Cardiol. 2008;31:437–442
  11. Georges JL, Loukac V, Poirier O, et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. J Mol Med. 2001;79:300–305
  12. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001;89:763–771
  13. Khreiss T, József L, Potempa LA, et al. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res. 2005;97:690–697
  14. Bermudez EA, Rifai N, Buring J, et al. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22:1668–1673
  15. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843
  16. Napoli C, Lerman LO, Nigris F, et al. Rethinking primary prevention of atherosclerosis-related diseases. Circulation. 2006;114:2517–2527
  17. Pai JK, Hankinson SE, Thadhani R, et al. Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis. 2006;186:113–120
  18. de Maat MPM, Kluft C. The association between inflammation markers, coronary artery disease and smoking. Vascul Pharmacol. 2002;39:137–139
  19. Hermann C, Graf K, Groh A, et al. Comparison of eleven commercial tests for chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol. 2002;40:1603–1609
  20. Hoffman M, Blum A, Baruch R, et al. Leukocytes and coronary heart disease. Atherosclerosis. 2004;172:1–6
  21. Sengoelge G, Födinger M, Skoupy S, et al. Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE modified fibronectin. Kidney Int. 1998;54:1637–1651
  22. Srinivasan S, Yeh M, Danziger EC, et al. Glucose regulates monocyte adhesion through endothelial production of interleukin-8. Circ Res. 2003;92:371–377
  23. Pradhan AD, Cook NR, Buring JE, Manson JE, Ridker PM. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol. 2003;23:650–655
  24. Kokura S, Wolf RE, Yoshikawa T, Granger DN, Aw TY. Postanoxic T lymphocyte-endothelial cell interactions induce tumor necrosis factor-production and neutrophil adhesion. Circ Res. 2000;86:1237–1244
  25. Tan J, Hua Q, Gao J, et al. Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction. Clin Cardiol. 2008;31:413–418
  26. Zairis MN, Adamopoulou EN, Manousakis SJ, et al. The impact of hs C-reactive protein and other inflammatory biomarkers on long-term cardiac mortality in patients with acute coronary syndromes. Atherosclerosis. 2007;194:397–402
  27. Zurawski SM, Vega F, Huyghe B, et al. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 1993;12:2663–2670
  28. Gabay C, Porter B, Guenette D, et al. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1 on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood. 1999;93:1299–1307
  29. Johnson LA, Clasper S, Holt AP, et al. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med. 2006;203:2763–2777
  30. Kawanami D, Maemura K, Takeda N, et al. C-reactive protein induces VCAM-1 gene expression through NF-κB activation in vascular endothelial cells. Atherosclerosis. 2006;185:39–46
  31. Luscinskas FW, Gimbrone MA. Endothelial dependent mechanism in chronic inflammatory leukocyte recruitment. Annu Rev Med. 1996;47:413–421
  32. Muller WA. Leukocyte-endothelial cell interactions in the inflammatory response. Lab Invest. 2002;82:521–533
  33. Beekhuizen H, Gevel JS. Endothelial cell adhesion molecules in inflammation and postischemic reperfusion injury. Transplant Proc. 1998;30:4251–4256
  34. Kokura S, Wolf RE, Yoshikawa T, et al. Postanoxic T lymphocyte-endothelial cell interactions induce tumor necrosis factor-a production and neutrophil adhesion. Circ Res. 2000;86:1237–1244
  35. Girndt M, Köhler H. Interleukin-10 (IL-10): an update on its relevance for cardiovascular risk. Nephrol Dial Transplant. 2003;18:1976–1979
  36. Aronson FL, Kimball AW. Coronary heart disease mortality and alcohol consumption Framingham. Am J Epidemiol. 1986;124:481–489
  37. Alho H, Sillanaukee P, Kalela A, et al. Alcohol misuse increases serum antibodies to oxidized LDL and CRP. Alcohol Alcohol. 2004;39:312–315

 This study was funded by the Department of Science and Technology, SR/SO/HS-6/2005, India. The Indian Council of Medical Research provided financial assistance to Hem Chandra Jha in the form of fellowship.

 Conflict of Interest: None.

PII: S0147-9563(09)00257-X

doi: 10.1016/j.hrtlng.2009.10.005

Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 4 , Pages 296-303 , July 2010